IVE240719C166000
- 21.92
- 0.000.00%
iShares S&P 500 Value ETF Newsroom
Elevance Health Shares Tumble on Indication of Rising Medical Costs
Procter & Gamble Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/17/2024 5.11% Deutsche Bank $171 → $176 Maintains Buy 07/10/2024 13.47% Citigroup $177 → $190
Keefe, Bruyette & Woods Reiterates Outperform on Bank of America, Raises Price Target to $48
Keefe, Bruyette & Woods analyst David Konrad reiterates Bank of America (NYSE:BAC) with a Outperform and raises the price target from $46 to $48.
Exxon Outlines up to 30-well Drilling Program for Guyana's Hammerhead Project
Bank of America Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Analysts' ratings for Bank of America (NYSE:BAC) over the last quarter vary from bullish to bearish, as provided by 11 analysts.Summarizing their recent assessments, the table below illustrates the
This Qualcomm Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in
UnitedHealth Analysts Boost Their Forecasts Following Upbeat Earnings
UnitedHealth Group (NYSE:UNH) reported better-than-expected second-quarter earnings on Tuesday.The company reported adjusted EPS of $6.80, up from $6.14 a year ago, beating the consensus of $6.66,
Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.TD Cowen
UnitedHealth Group Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/17/2024 11.64% Morgan Stanley $595 → $615 Maintains Overweight 07/09/2024 7.28% Cantor Fitzgerald $591
Johnson & Johnson in Charts: Innovative Medicine, MedTech and Total U.S. Sales Highest in Q2
Chevron Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/17/2024 6.27% Bernstein $183 → $167 Downgrades Outperform → Market Perform 07/12/2024 14.55%
Johnson & Johnson reports Q2 2024 results
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2024
Nasdaq Futures Tumble as Rotation Out of Tech Stocks Continues
JP Morgan Chief Calls for "Patience" With Fed's Next Interest Rate Move
What's Going On With Exxon Mobil Shares Today?
Exxon Mobil Corporation (NYSE:XOM) reportedly shut down its 251,800 barrels per day Joliet, Illinois refinery on Monday due to a power outage caused by a storm.The refinery shutdown occurred due to
ASML, United Airlines And 3 Other Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Johnson & Johnson (NYSE:JNJ) to report
Dow Jones Closes At Record High As Traders Turn Bullish Amid Hopes Of Fed Cutting Rates In September
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index remaining in the "Greed" zone on Tuesday.U.S. stocks closed higher on Tuesday, with the Dow
GameStop, Meta Platforms, TSMC, Bank Of America, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wall Street experienced another notable day with the bulls driving the market upward, fueled by expectations of the Federal Reserve's rate cuts in September.
Options Market Statistics: Bank of America Shares Surge, Options Pop on Promising Net Interest Income Rebound Forecast
News Highlights